9th Congress of ECCO, Copenhagen
The 9th Congress of ECCO was held on February 20-22, 2014 at Bella Center Copenhagen in Copenhagen, Denmark. A record number has been set! ECCO is proud to have hosted 5,175 delegates at ECCO'14. Thank you to all delegates for your participation!
Discover the ECCO'14 Photo Gallery!
Statistics of 9th Congress of ECCO
ECCO14_Copenhagen_General_statistics.pdf
ECCO14_Copenhagen_Country_statistics.pdf
The Secret Files of ECCO - The ECCO Film 2014:
Certificate of attendance
Please download your certificate of attendance from your My User Area.
Congratulations to the ECCO'14 Abstract Awardees
Top 11 Posters:
- “The absence of the Triggering Receptor Expressed on Myeloid Cells type-2 (TREM-2) induces a transmissible and protective intestinal microbiota for colitis and colitis associated cancer" (DOP008), Marco Genua et al, Humanitas Research Hospital, Rozzano, Milan, Italy
- "The role of optineurin in macrophage cytokine secretion and Crohn's disease" (DOP014), Thean Soon Chew et al, University College London, United Kingdom
- "Familial risk of inflammatory bowel disease: a population-based cohort study 1977–2011" (DOP021), Frederik Trier Moller et al, Southern University of Denmark, Odense, Denmark
- "Lémann Index assessment over time in Crohn's disease patients treated with anti TNFs: a pilot observational cohort study" (DOP036), Gionata Fiorino et al, Humanitas Research Hospital, Rozzano, Milan, Italy
- "Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth" (DOP041), Mette Julsgaard et al, Aarhus University Hospital, Aarhus, Denmark
- "Predicting the individal risk of acute severe colitis at diagnosis" (DOP049), Monica Cesarini et al, University of Oxford, United Kingdom
- "Predictors of formation of antibodies to infliximab (ATI) and secondary loss of response in IBD patients treated with infliximab" (DOP062), Bella Ungar et al, Chaim Sheba Medical Center, Ramat Gan, Israel
- "Autoimmune sclerosing cholangitis is associated with small bowel ulceration on capsule enteroscopy" (DOP065), Bu'Hussain Hayee et al, King's College Hospital NHS Foundation Trust, London, United Kingdom
- "Long-term natural history of postoperative recurrence in patients on preventive treatment with azathioprine" (DOP081), Eugeni Domènech et al, Hospital Universitari Germans Trias i Pujol and CIBERehd, Badalona, Spain
- "Defunctioning ileostomy does not prevent anastomotic leaks after restorative procto-colectomy with ileal pouch-anal anastomosis in patients treated with anti-TNF and steroids" (DOP088), Saloomeh Sahami et al, Academic Medical Center, Amsterdam, Netherlands
- "Risk of dysplasia and cancer complicating colonic strictures in inflammatory bowel disease: a GETAID study" (DOP095), Mathurin Fumery et al, CHU Amiens, Amiens, France
Y-ECCO Abstract Awards:
- "Innate lymphoid cells accumulate in IBD" (OP001), Alessandra Geremia et al, University of Oxford, Oxford, United Kingdom
- "Is elderly-onset ulcerative colitis a different entity? - Natural disease course and treatment response compared to adult-onset disease in the population-based IBD-SL cohort" (OP005), Steven Jeuring et al, Maastricht University Medical Center, Maastricht, Netherlands
- "The cost of investigations and medical treatment including biological therapy in a European inception cohort from the biological era - An ECCO-EpiCom study" (OP008), Johan Burisch et al, Herlev University Hospital, Herlev, Denmark
- "Gut homing markers in perianal Crohn's fistulae" (OP015), Nuha A. Yassin et al, St Mark's Hospital and Academic Institute, London, United Kingdom
- "Smoking cessation alters intestinal microbiota - further insights from quantitative investigations on human faecal samples using FISH and qPCR" (DOP016), Luc Biedermann et al, University Hospital Zurich, Zurich, Switzerland
IIS Abstract Award:
- "Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study" (OP023), Michael Kamm et al, St Vincent's Hospital & University of Melbourne, Australia